223 related articles for article (PubMed ID: 25668935)
1. Consensus evidence-based guidelines for use of insulin pump therapy in the management of diabetes as per Indian clinical practice.
Kesavadev J; Jain SM; Muruganathan A; Das AK;
J Assoc Physicians India; 2014 Jul; 62(7 Suppl):34-41. PubMed ID: 25668935
[TBL] [Abstract][Full Text] [Related]
2. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
[TBL] [Abstract][Full Text] [Related]
3. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
4. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
Szypowska A; Pańkowska E; Lipka M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
[TBL] [Abstract][Full Text] [Related]
5. Management of diabetes mellitus: is the pump mightier than the pen?
Pickup JC
Nat Rev Endocrinol; 2012 Feb; 8(7):425-33. PubMed ID: 22371161
[TBL] [Abstract][Full Text] [Related]
6. Consensus recommendations for the management of hyperglycaemia in critically ill patients in the Indian setting.
Mukherjee JJ; Chatterjee PS; Saikia M; Muruganathan A; Das AK;
J Assoc Physicians India; 2014 Jul; 62(7 Suppl):16-25. PubMed ID: 25668933
[TBL] [Abstract][Full Text] [Related]
7. Insulin pump therapy in adults.
Didangelos T; Iliadis F
Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S109-13. PubMed ID: 21864741
[TBL] [Abstract][Full Text] [Related]
8. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
[TBL] [Abstract][Full Text] [Related]
9. Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital.
Thompson B; Korytkowski M; Klonoff DC; Cook CB
J Diabetes Sci Technol; 2018 Jul; 12(4):880-889. PubMed ID: 29681173
[TBL] [Abstract][Full Text] [Related]
10. Consensus evidence-based guidelines for in-patient management of hyperglycaemia in non-critical care setting as per Indian clinical practice.
Gangopadhyay KK; Bantwal G; Talwalkar PG; Muruganathan A; Das AK;
J Assoc Physicians India; 2014 Jul; 62(7 Suppl):6-15. PubMed ID: 25668932
[TBL] [Abstract][Full Text] [Related]
11. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
12. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
Pickup JC; Sutton AJ
Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
[TBL] [Abstract][Full Text] [Related]
13. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
14. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
15. Selection for and initiation of continuous subcutaneous insulin infusion. Proceedings from a workshop.
Hanas R
Horm Res; 2002; 57 Suppl 1():101-4. PubMed ID: 11979036
[TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
Radermecker RP; Scheen AJ
Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
[TBL] [Abstract][Full Text] [Related]
17. Insulin pumps.
Pickup J
Int J Clin Pract Suppl; 2011 Feb; (170):16-9. PubMed ID: 21323808
[TBL] [Abstract][Full Text] [Related]
18. Insulin pump therapy and rapid acting insulin: what have we learned?
Zinman B
Int J Clin Pract Suppl; 2001 Sep; (123):47-50. PubMed ID: 11594299
[TBL] [Abstract][Full Text] [Related]
19. Treatment of diabetes mellitus using an external insulin pump: the state of the art.
Hanaire H; Lassmann-Vague V; Jeandidier N; Renard E; Tubiana-Rufi N; Vambergue A; Raccah D; Pinget M; Guerci B
Diabetes Metab; 2008 Sep; 34(4 Pt 2):401-23. PubMed ID: 18951116
[TBL] [Abstract][Full Text] [Related]
20. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
Bruttomesso D; Costa S; Baritussio A
Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
